Tumor-Fatigue-Consultation of the Bayerische Krebsgesellschaft e.V. – Evaluation of a nationwide structure of care provision in Bavaria serving as model for other federal states

Tumor-Fatigue-Consultation of the Bayerische Krebsgesellschaft e.V. – Evaluation of a nationwide structure of care provision in Bavaria serving as model for other federal states - TF-Consultation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028264

Enrollment

320

Registered

2022-03-01

Start date

2022-03-01

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue C00-D48

Interventions

Group 1: TF-Consultation

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patient-reported fatigue, confirmed diagnosis of cancer, residence in Bavaria, and informed consent to participate in this study.

Exclusion criteria

Exclusion criteria: No patient-reported fatigue, no confirmed diagnosis of cancer, no residence in Bavaria, not informed consent to participate in this study, inability to fill in the questionnairs by themselves, and insufficient German language skills.

Design outcomes

Primary

Measure	Time frame
Patient-reported outcomes (PROs) and Patient-reported experience measures (PREMs) • Fatigue measured by Brief Fatigue Inventory (BFI) before TF-Consulatation and 10 weeks (± 2 weeks) after TF-Consultation	—

Secondary

Measure	Time frame
Patient-reported outcomes (PROs) and Patient-reported experience measures (PREMs) • Patient satisfaction with TF-Consultation directly after TF-Consultation and 10 weeks (± 2 weeks) after TF-Consultation, • Suggestions for improvement of the TF-Consultation directly after and 10 weeks (± 2 weeks) after TF-Consultation and • Implementation of the recommended interventions as well as potential problems and barriers 10 weeks (± 2 weeks) after TF-Consultation. Tumor device centres will document information about structure and performance of the TF-Consultations.	—

Measure

Time frame

Patient-reported outcomes (PROs) and Patient-reported experience measures (PREMs) • Patient satisfaction with TF-Consultation directly after TF-Consultation and 10 weeks (± 2 weeks) after TF-Consultation, • Suggestions for improvement of the TF-Consultation directly after and 10 weeks (± 2 weeks) after TF-Consultation and • Implementation of the recommended interventions as well as potential problems and barriers 10 weeks (± 2 weeks) after TF-Consultation. Tumor device centres will document information about structure and performance of the TF-Consultations.

—

Countries

Germany

Contacts

Public ContactIrene Fischer

Institut für Tumor-Fatigue-Forschung

irene.fischer@fatigue-forschung.de0049 9104 89 79 69

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026